At the 2025 Cell & Gene Therapy Summit in London, we teamed up with IBTV once again to find out what thoughts attendees had about the challenges facing the CGT field. One key theme was on everyone’s minds: access to funding.  

Watch the video below.

Read more about funding and investment in these articles:

The Brutality of the Investment Landscape

Funding Pharma’s All-Female Leaders

Researchers Respond to NIH Funding Cuts

Eight Reflections on the Acquisition of Bluebird Bio

Political Upheaval Forces Medical Centers to Adapt

The Trump Effect on Biopharma: FDA Disruption, Tariffs, and Funding Cuts